- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06110624
The MuSt-PC: a Feasibility Study on Intent to Use a Tool With Regard to Symptom Management
The MuSt-PC: A Multidimensional Strategy to Improve Quality of Life of Patients With Multiple Symptoms and Palliative Care Needs - Feasibility Study
Study Overview
Detailed Description
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Groningen, Netherlands
- University Medical Center Groningen
-
Leiden, Netherlands
- LUMC
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
Residents (in Dutch: Arts In Opleiding tot Specialist (AIOS) or Arts Niet In Opleiding tot Specialist (ANIOS)), medical specialists and nurse practitioners working in the following disciplines are invited to participate:
- General practice
- Nursing home
Hospital:
- Clinical geriatrics
- Medical oncology
- Radiation oncology
- Pulmonology
- Cardiology
Exclusion Criteria:
HCPs who were formally trained in palliative care ("kaderopleiding palliatieve zorg", "Masteropleiding Palliative Medicine for Health Care Professionals at Cardiff University" or "post-HBO opleiding palliatieve zorg") and/or who have been or are currently a consultant of a palliative care consultation team are considered specialists in palliative care, are excluded from participation.
GHCPs (e.g. nurses) who cannot independently decide about CDSS recommendation adherence, including drug interventions, are excluded from participation.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Arm 1
A targeted sample of healthcare providers (HCPs) who are not specialized in palliative care (GHCPs) constitutes the study population.
|
A survey study will be conducted to evaluate if GHCPs have the Intention to Use (IU) MuSt-PC in daily practice.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Questions evaluating Intention to Use (IU)
Time Frame: after 5 times use of the MuSt-PC tool within 3 months
|
Questions evaluating Intention to Use (IU) (7-point Likert scales)
|
after 5 times use of the MuSt-PC tool within 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Questions evaluating other modified TAM domains
Time Frame: after 5 times use of the MuSt-PC tool within 3 months
|
Questions evaluating other modified TAM domains: Perceived Usefulness, Perceived Ease-of-Use, Attitude, Compatibility, Subjective norm, Facilitators, Habit (7-point Likert Scales).
|
after 5 times use of the MuSt-PC tool within 3 months
|
|
Perceived benefits and disadvantages of using MuSt-PC
Time Frame: after 5 times use within 3 months
|
Perceived benefits and disadvantages of using MuSt-PC (open-ended questions).
|
after 5 times use within 3 months
|
|
Suggestions to improve the MuSt-PC CDSS
Time Frame: after 5 times of the MuSt-PC tool within 3 months
|
Suggestions to improve the MuSt-PC CDSS (open-ended question).
|
after 5 times of the MuSt-PC tool within 3 months
|
|
An overview of the content of questions of participating GHCPs regarding MuSt-PC use.
Time Frame: after 5 times use within 3 months
|
An overview of the content of questions of participating GHCPs regarding MuSt-PC use.
Questions will be analyzed qualitatively; coding will be done independently by two researchers.
In case of disagreement, consensus will be achieved through discussion.
Coding will result in categorization of question subject.
Categorizations are ranked from most prevalent to least prevalent question subject (proportion of respondents).
|
after 5 times use within 3 months
|
|
Most useful elements of MuSt-PC will be evaluated with a multiple-choice question.
Time Frame: after 5 times use within 3 months
|
Most useful elements of MuSt-PC will be evaluated with a multiple-choice question.
(multiple answers allowed) Frequency and percentage of total respondents who chose the multiple choice answer possibilities will be evaluated
|
after 5 times use within 3 months
|
|
Mean scores of HCPs adherence to CDSS recommendations
Time Frame: after 5 times use of the MuSt-PC tool within 3 months
|
Mean scores (5-point Likert scale) of HCPs adherence to CDSS recommendations (each time using MuSt-PC)
|
after 5 times use of the MuSt-PC tool within 3 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
A focus group meeting will be conducted if ≥20% of all participating GHCPs have insufficient intention to use MuSt-PC and/or perceive MuSt-PC insufficiently useful and/or perceive MuSt-PC insufficiently easy to use
Time Frame: after 5 times use of the MuSt-PC tool within 3 months
|
A focus group meeting will be conducted if ≥20% of all participating GHCPs have insufficient intention to use MuSt-PC and/or perceive MuSt-PC insufficiently useful and/or perceive MuSt-PC insufficiently easy to use:
|
after 5 times use of the MuSt-PC tool within 3 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: An KL Reyners, MD, PhD, University Medical Center Groningen
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 11265
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Palliative Medicine
-
Azienda Usl di BolognaIRCCS Azienda Ospedaliero-Universitaria di BolognaCompletedPalliative Care | Palliative Medicine | Hospice and Palliative Care NursingItaly
-
Charite University, Berlin, GermanyKing's College Hospital NHS Trust; National and Kapodistrian University of... and other collaboratorsWithdrawn
-
Mayo ClinicTerminatedPalliative MedicineUnited States
-
University of Colorado, DenverNational Institute of Nursing Research (NINR)CompletedCardiovascular Disease | Palliative MedicineUnited States
-
National Taiwan University HospitalRecruitingPalliative Medicine | Hospice | Terminal CancerTaiwan
-
Allina Health SystemCompletedPalliative Care | Spine | Medical Oncology | Primary Care | Integrative Medicine | Cardiology | Physical and Rehabilitation Medicine | Orthopedics | Pulmonary MedicineUnited States
-
University Medical Center GroningenCompletedPalliative MedicineNetherlands
-
University of SouthamptonGreat Ormond Street Hospital for Children NHS Foundation Trust; Alder Hey Children... and other collaboratorsUnknownPediatric ALL | Palliative MedicineUnited Kingdom
-
Vanderbilt University Medical CenterCompletedEducation, Medical | Care, Palliative | Education, Medical, Graduate | Medicine, PalliativeUnited States
-
Region SkaneActive, not recruitingPalliative Care | Palliative Medicine | Elderly PersonSweden
Clinical Trials on Survey
-
Johns Hopkins Bloomberg School of Public HealthPontificia Universidad JaverianaCompletedNoncommunicable Diseases | Surveys and QuestionnairesColombia
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedSarcoma | Breast Carcinoma | Head and Neck CarcinomaUnited States
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker Cochin; Université de Cergy PontoiseCompleted
-
Sarasota Memorial Health Care SystemEnrolling by invitation
-
Ohio State UniversityWithdrawnMedicare Part DUnited States
-
Johns Hopkins Bloomberg School of Public HealthIfakara Health InstituteCompletedNoncommunicable Diseases | Surveys and QuestionnairesTanzania
-
Memorial Sloan Kettering Cancer CenterCompletedInpatients With Limited English ProficiencyUnited States
-
Lawson Health Research InstituteCompletedEvaluation of an Introductory Videotape Intervention to Improve Cardiac Rehabilitation ParticipationMyocardial Infarction | Unstable Angina | Coronary Angioplasty | Coronary Artery Bypass SurgeryCanada
-
University GhentCompletedStroke | Upper Extremity Paresis | Survey